Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-24

FDA Approved: TRANDOLAPRIL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for a generic Trandolapril product from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trandolapril (trandolapril)

Snippet

SUPPL AP for TRANDOLAPRIL (TRANDOLAPRIL)